Textiles Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.

Press releases published on September 3, 2026

Sep. 3, 2026

Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

New U.S. Treatment Recommendations Published for Severe Alopecia Areata in Adults

Indeterminate GlobeNewswire

Sep. 3, 2026

FingerMotion Announces Non-Binding Three-Party MOU with Lyken.AI and BlueFlare and Provides Update on Alberta Corridor Gas-Supply Discussions

Indeterminate GlobeNewswire

Sep. 3, 2026

Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Quanex Building Products Announces Third Quarter 2026 Results

Indeterminate GlobeNewswire

Sep. 3, 2026

PicPay Announces Integration with Claude, Expanding Customer Access to Financial Information through Generative AI

Indeterminate GlobeNewswire

Sep. 3, 2026

Retirement Heroes Announces Their Founder, Shelby Green, Shares Retirement Income Planning Insights on KXTV 10's Coastal Living

Indeterminate GlobeNewswire

Sep. 3, 2026

Five Top Sofa Fabric Makers in China 2026: Advancing Textile Quality and Sustainable Upholstery

Indeterminate EIN Presswire

Sep. 3, 2026

Lianhe Sowell International Group Ltd. Announces Closing of an $11 Million Best-efforts Follow-on Public Offering

Indeterminate GlobeNewswire

Sep. 3, 2026

Vivani Medical Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Canada’s Drug Agency Issues Recommendation to Reimburse Yorvipath® (palopegteriparatide injection) With Conditions for Eligible Adults With Chronic Hypoparathyroidism

Indeterminate GlobeNewswire

Sep. 3, 2026

L’Agence des médicaments du Canada recommande le remboursement de Yorvipathᴹᴰ (injection de palopegteriparatide), sous certaines conditions, pour les adultes admissibles atteints d’hypoparathyroïdie chronique.

Indeterminate GlobeNewswire

Sep. 3, 2026

LB Pharmaceuticals to Participate in Upcoming September Investor Events

Indeterminate GlobeNewswire

Sep. 3, 2026

Agomab to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Ambarella and Macnica Enter a Long-Term Strategic Distribution Agreement to Accelerate Edge AI Infrastructure and Physical AI Adoption

Indeterminate GlobeNewswire

Sep. 3, 2026

Ambarella Engages Capgemini to Help Accelerate Enterprise Adoption of Edge and Physical AI

Indeterminate GlobeNewswire

Sep. 3, 2026

Immuneering to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Latigo Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Sep. 3, 2026

Spyre Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire